XML 150 R4.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2019
Dec. 31, 2018
Current assets:    
Cash and cash equivalents $ 94.8 $ 69.2
Restricted cash 57.4 59.0
Accounts receivable 506.1 467.7
Prepaid expenses and other current assets 97.5 66.2
Total current assets 755.8 662.1
Property and equipment, net 1,959.3 1,634.8
Operating lease right-of-use assets 276.5  
Goodwill 2,305.2 2,100.8
Intangible assets, net 476.3 443.4
Deferred income tax assets 2.9 42.9
Other long-term assets 304.7 291.0
Total assets [1] 6,080.7 5,175.0
Current liabilities:    
Current portion of long-term debt 39.3 35.8
Current operating lease liabilities 40.4  
Accounts payable 94.6 90.0
Accrued payroll 210.5 188.4
Accrued interest payable 32.4 24.4
Other current liabilities 303.8 333.9
Total current liabilities 721.0 672.5
Long-term debt, net of current portion 3,023.3 2,478.6
Long-term operating lease liabilities 243.8  
Self-insured risks 117.2 119.6
Other long-term liabilities 42.7 85.6
Total liabilities 4,148.0 3,356.3
Commitments and contingencies
Redeemable noncontrolling interests 239.6 261.7
Encompass Health shareholders’ equity:    
Common stock, $.01 par value; 200,000,000 shares authorized; issued: 113,230,774 in 2019; 112,492,690 in 2018 1.1 1.1
Capital in excess of par value 2,369.9 2,588.7
Accumulated deficit (526.5) (885.2)
Treasury stock, at cost (14,637,858 shares in 2019 and 13,566,209 shares in 2018) (492.3) (427.9)
Total Encompass Health shareholders’ equity 1,352.2 1,276.7
Noncontrolling interests 340.9 280.3
Total shareholders’ equity 1,693.1 1,557.0
Total liabilities and shareholders’ equity [1] $ 6,080.7 $ 5,175.0
[1]
Our consolidated assets as of December 31, 2019 and December 31, 2018 include total assets of variable interest entities of $215.0 million and $197.5 million, respectively, which cannot be used by us to settle the obligations of other entities. Our consolidated liabilities as of December 31, 2019 and December 31, 2018 include total liabilities of the variable interest entities of $41.1 million and $50.8 million, respectively. See Note 3, Variable Interest Entities.